Africa: Acoziborole Winthrop, Developed by DNDi and Sanofi, receives European Medicines Company optimistic opinion as Three-tablet, Single-Dose Remedy For Most Widespread Type of Sleeping Illness
Kinshasa / Paris / Geneva / Amsterdam — • Advice primarily based on Part II/III research demonstrating as much as 96 per cent success charges at 18 months throughout each early and superior phases of T.b. gambiense, the most typical kind of sleeping illness • The remedy, given as a single dose of three tablets, might supply…
